Prescription Drug Management: Is it a Level 3 or a Level 4?

June 29th, 2017 - J. Paul Spencer, CPC, COC
Categories:   Audits/Auditing   Drugs|Pharmaceuticals|FDA  
0 Votes - Sign in to vote or comment.

If you place four auditors around a table and place a typical established patient visit in front of them, what tends to follow is a scene that resembles less about building consensus and more along the lines of a National Geographic special regarding the hunting habits of hyenas. Perhaps no one area is more contentious and liable to lead to such a scene as a simple three-word phrase from the Table of Risk: "Prescription Drug Management."

In the early days on the E&M Guidelines, many physicians interpreted this small, unassuming phrase as an invitation to increase the complexity of simply visits based on the prescribing of any medication. With every new generation of auditors coming on to the scene, this myth seems to reappear and propagate anew.

First, a definition of these three words, as it applies to the E&M Guidelines, needs to be found and understood. In general, prescription drug management can be any one of the following:

  • Writing a new prescription;

  • Reviewing, but not changing, current prescribed medications and dosages;

  • Discontinuing an existing prescription; and

  • A decision not to add new medications to the current drug regimen due to potential harmful side effects or interactions.

The duration of the prescription drug regimen is not taken into account when applying these factors to the Table of Risk. The problem with jumping forward with moderate complexity Medical Decision Making (MDM) simply on the strength of the prescription drug management becomes a question of acuity. The Table of Risk is but one of three factors that determines the level of MDM. In many cases, the category of problem necessitating the visit will be the determining factor for MDM. As an auditor, it usually comes down to a decision regarding whether a presenting problem is self-limiting/minor or a new problem to the examining physician with no workup planned. A patient can present with two minor problems and the MDM still falls under low complexity.

The auditor must walk a fine line between making a sound auditing determination and leaving it up to the physician to paint a clear picture of the acuity of the patient. There are going to be times where the presenting problem reaches the acuity of a 99214, but the documentation doesn't support it. Conversely, there will be other times when the presenting problem appears to be minor, but the physician's documentation points to a more complicated condition.

In the end, if the documentation is not pointing to one, clear final answer, consult the physician. While it is tempting to defer to a higher level based on the fact that physicians go through ten years of intense scientific training to become doctors, different physicians will have different comfort levels when measuring patient acuity. Prescription Drug Management may look like a surefire level 4 on paper, but in questionable cases, the physician is the best judge of acuity.

###

Questions, comments?

If you have questions or comments about this article please contact us.  Comments that provide additional related information may be added here by our Editors.


Latest articles:  (any category)

​​Polysomnography Services Under OIG Scrutiny
September 2nd, 2021 - Raquel Shumway
The OIG conducted a study dated June 2019 wherein they indicated that there were approximately $269 million in overpayments for polysomnography services for the period of 2014 through 2015. According to the OIG “These errors occurred because the CMS oversight of polysomnography services was insufficient to ensure that providers complied with Medicare requirements and to prevent payment of claims that didn’t meet those requirements.” So what are those requirements?
Medicare Advantage - The Fastest Growing Government-Funded Program Undergoing Multiple Fraud Investigations
August 16th, 2021 - Aimee Wilcox, CPMA, CCS-P, CST, MA, MT, Director of Content
Medicare Advantage is the fastest growing form of government-funded healthcare and the rate of fraud within this segment has come under increased scrutiny. Funding is determined by the health status of each beneficiary; therefore, accurate coding based on detailed documentation makes the medical record vital to the process because some ...
Billing Dental Implants under Medical Coverage
August 12th, 2021 - Christine Woolstenhulme, QCC, QMCS, CPC, CMRS
Implants can be costly to the patient and the provider, and it is crucial to understand how to bill a patient’s medical insurance to ensure there is adequate coverage for the best treatment. Implants are commonly billed in a dental office under a patient’s medical benefits.    Implants could be considered ...
New Codes for COVID Booster Vaccine & Monoclonal Antibody Products
August 10th, 2021 - Wyn Staheli, Director of Research
New codes have been announced for the COVID-19 booster vaccine, Novavax vaccine, and monoclonal antibody treatment.
Medicare's ABN Booklet Revised
July 29th, 2021 - Wyn Staheli, Director of Research
The “Medicare Advance Written Notices of Non-coverage” booklet, published by CMS’s Medicare Learning Network, was updated. This article discusses the changes to this booklet regarding the use of the ABN.
Chronic Pain Coding Today & in the Future
July 19th, 2021 - Wyn Staheli, Director of Research
Properly documenting and coding chronic pain can be challenging. As is commonly the case with many conditions, over the years, there has been a shift in the identification of different types of pain, including chronic pain. Understanding where we are now and where we are going will help your organization prepare for the future by changing documentation patterns now.
How Does Global and Professional Direct Contracting (GPDC) Affect Risk Adjustment?
July 15th, 2021 - Aimee Wilcox, CPMA, CCS-P, CST, MA, MT, Director of Content
CMS recently announced the 53 Direct Contracting Entities (DCEs) that will be participating in the April 1, 2021 through December 31, 2021 Global and Professional Direct Contracting (GPDC) Model. Among those participating is Clover Health Partners, who runs an in-home primary care program that has the potential to help Medicare ...



Home About Contact Terms Privacy

innoviHealth® - 62 E 300 North, Spanish Fork, UT 84660 - Phone 801-770-4203 (9-5 Mountain)

Copyright © 2000-2021 innoviHealth Systems®, Inc. - CPT® copyright American Medical Association